Shahid Nazir Wani

Dr. S. N. Wani is a highly accomplished pharmacology expert with dual exposure to academia and the pharmaceutical industry. With over 7 years of multidisciplinary experience, he specializes in integrating scientific research with practical quality systems. His academic roles are complemented by strategic advisory positions where he designs and implements regulatory-compliant clinical quality frameworks.

Dr. Wani’s passion lies in translational pharmacology, clinical research, and quality assurance, driving innovations in drug safety, pharmacovigilance, and nanomedicine. His methodical approach is backed by Lean Six Sigma Black Belt certification, ensuring process optimization at every stage. As a lifelong learner and educator, he is committed to fostering knowledge transfer and promoting best practices in pharmaceutical sciences.

1. Ph.D. in Pharmaceutical Sciences (Ongoing)

Chitkara University  India  2021 – Present

Master’s Project:  Nanomedicine-based drug delivery systems and clinical applications

2. Master of Pharmacy (Pharmacology)

Arya College of Pharmacy  Jaipur, India  (2016 – 2018)

3. Bachelor of Pharmacy 

Shekhawati College of Pharmacy  Jhunjhunu, India  (2012 – 2016)  

Dr. Wani’s scholarly contributions span innovative drug delivery, nanotechnology, neuropharmacology, and clinical research methodologies. He has published extensively in peer-reviewed journals, and contributed chapters to authoritative texts.

1. Nanostructured Lipid Carriers (NLCs) for NSAID Delivery: Demonstrated improved bioavailability and reduced gastrointestinal toxicity, published in Scripta Medica (June 2025).

2. PLGA Nanoparticles in Cardiovascular Therapeutics: Evaluated sustained release formulations, Bentham Science (Apr 2025).

3. Regenerative Medicine Approaches in Pharma: Authored comprehensive reviews on cell-based therapies, Springer Nature (Jun 2025).

4. Artificial Intelligence in Clinical Prescriptions: Explored algorithmic decision-making models, Bentham Science (Jul 2024).

5. Opioid Addiction Neuroplasticity: Investigated molecular pathways underpinning tolerance and dependence, Springer (Sep 2024).

1. Lean Six Sigma Black Belt – Simplilearn (Aug 2021)

2. Good Clinical Practice (GCP) – NDATCTN (valid through Oct 2026)

3. Professional Pharmacist License – Jammu & Kashmir Pharmacy Council (valid through Sep 2028)

4. Pharmacovigilance & Drug Safety – PDPV Certification (2024)

5. Systematic Review & Meta-Analysis – Clinical Medicine Education (2025)

6. Evidence Synthesis & GRADE Framework – NIPER Hyderabad (2025)

7. Cell Therapy & Regenerative Medicine – BITS Pilani (2025)

1. Alaina Healthcare Pvt Ltd – Quality Assurance Executive

2. Oversaw process validations, batch documentation, and cGMP compliance in manufacturing.

3. Coordinated with regulatory inspectors during audits and inspections.

4. Shield Formulation Pvt Ltd – Research and Development Associate

5. Developed formulations for controlled-release drug products.

6. Conducted stability studies and analytical method validation.

7. Emcure Pharmaceuticals Ltd – Pharmacovigilance Trainee

8. Monitored adverse event reports, conducted signal detection and risk assessment.

9. Collaborated on safety data reporting aligned with CDSCO and global standards.

1. Regulatory Compliance: ICH-GCP, FDA, EMA, PCI, RUHS, CDSCO

2. Quality Systems: SOP development, audit management, pharmacovigilance frameworks

3. Process Optimization: Lean Six Sigma, validation protocols, technology transfer

4. Research Methods: Clinical trial design, systematic reviews, meta-analyses, evidence synthesis

5. Data Analytics: Minitab, SPSS, RevMan, Rayyan, Excel, Power BI, TableauRegulatory Compliance: ICH-GCP, FDA, EMA, PCI, RUHS, CDSCO

6. Quality Systems: SOP development, audit management, pharmacovigilance frameworks

7. Process Optimization: Lean Six Sigma, validation protocols, technology transfer

8. Research Methods: Clinical trial design, systematic reviews, meta-analyses, evidence synthesis

9. Data Analytics: Minitab, SPSS, RevMan, Rayyan, Excel, Power BI, Tableau

• At CliniVance, Dr. Wani plays a pivotal role in embedding a culture of quality and scientific rigor. His cross-domain expertise enhances clinical research integrity and accelerates innovation pipelines. By bridging academic insights with real-world pharmaceutical demands, he ensures CliniVance stays ahead in regulatory preparedness and clinical excellence.

• He is passionate about mentoring young professionals and cultivating an environment of continuous improvement and ethical research practices within the company.